Response to 'Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'' by Gremese et al

Ann Rheum Dis. 2023 Jan;82(1):e6. doi: 10.1136/annrheumdis-2020-219337. Epub 2020 Nov 3.

Authors

Shintaro Akiyama¹, Shadi Hamdeh², Dejan Micic¹, Atsushi Sakuraba³

Affiliations

¹ Section of Gastroenterology, Department of Medicine, The University of Chicago Medicine, Chicago, Illinois, USA.
² Division of Gastroenterology, Hepatology and Motility, Department of Internal Medicine, University of Kansas, Kansas City, Kansas, USA.
³ Section of Gastroenterology, Department of Medicine, The University of Chicago Medicine, Chicago, Illinois, USA asakurab@medicine.bsd.uchicago.edu.

PMID: 33144306
DOI: 10.1136/annrheumdis-2020-219337

No abstract available

Keywords: autoimmune diseases; biological therapy; glucocorticoids.

Publication types

Meta-Analysis
Systematic Review
Comment

MeSH terms

Autoimmune Diseases* / complications
Autoimmune Diseases* / epidemiology
COVID-19*
Humans
Prevalence